γδ T cells link innate and adaptive immune responses: Focus on human Vγ9/Vδ2 and Vδ1 T cells

Chemical Immunology and Allergy

Volumn 86, Issue , 2005, Pages 151-183

  Holtmeier, Wolfgang ^a   Kabelitz, Dieter ^b  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALIPHATIC AMINE; BACTERIAL ANTIGEN; BISPHOSPHONIC ACID DERIVATIVE; CD3 ANTIGEN; CHEMOKINE; CYTOKINE; GLYCOLIPID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MEVALONIC ACID; PAMIDRONIC ACID; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; T LYMPHOCYTE RECEPTOR DELTA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN; TOLL LIKE RECEPTOR; ZOLEDRONIC ACID; ANTIGEN; CELL SURFACE RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR; MEMBRANE PROTEIN;

ANTIGEN RECOGNITION; ANTIINFLAMMATORY ACTIVITY; BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; CELL POLARITY; CYTOKINE PRODUCTION; CYTOTOXICITY; GRAM NEGATIVE BACTERIUM; HUMAN; IMMUNE RESPONSE; IMMUNOSURVEILLANCE; IMMUNOTHERAPY; INTESTINE EPITHELIUM; LYMPHOCYTE MIGRATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL; ADAPTATION; CYTOLOGY; DRUG EFFECT; EPITHELIUM; IMMUNOLOGY; INFECTION; INNATE IMMUNITY; INTESTINE; LYMPHOCYTE ACTIVATION; METABOLISM; MICROBIOLOGY; NEOPLASM;

ADAPTATION, PHYSIOLOGICAL; ANTIGENS; CHEMOKINES; EPITHELIUM; GRAM-NEGATIVE BACTERIA; HUMANS; IMMUNITY, NATURAL; INFECTION; INTESTINES; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; NEOPLASMS; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; RECEPTORS, CELL SURFACE; T-LYMPHOCYTE SUBSETS; TOLL-LIKE RECEPTORS;

EID: 21344461738     PISSN: 16602242     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (193)

1. Hayday AC: γ/δ cells: A right time and a right place for a conserved third way of protection. Annu Rev Immunol 2000;18:975-1026.
2. Cai JL, Tucker PW: γ/δ T cells: Immunoregulatory functions and immunoprotection. Chem Immunol 2001;79:99-138.
3. Mak TW, Ferrick DA: The γ/δ T-cell bridge: Linking innate and acquired immunity. Nat Med 1998;4:764-765.
4. Kabelitz D, Wesch D: Features and functions of γδ T lymphocytes: Focus on chemokines and their receptors. Crit Rev Immunol 2003;23:339-370.
5. Kabelitz D, Wesch D, Hinz T: γ/δ T cells, their T cell receptor usage and role in human diseases. Springer Semin Immunopathol 1999;21:55-75.
6. Bukowski JF, Morita CT, Brenner MB: Recognition and destruction of virus-infected cells by human γ/δ CTL. J Immunol 1994;153:5133-5140.
7. Verjans GM, Roest RW, Van Der KA, Van Dijk G, Van Der Meijden WI, Osterhaus AM: Isopentenyl pyrophosphate-reactive Vγ9Vδ2 T helper 1-like cells are the major γ/δ T cell subset recovered from lesions of patients with genital herpes. J Infect Dis 2004;190:489-493.
8. Pfeffer K, Schoel B, Plesnila N, Lipford GB, Kromer S, Deusch K, Wagner H: A lectin-binding, protease-resistant mycobacterial ligand specifically activates Vγ9+ human γ/δ T cells. J Immunol 1992;148:575-583.
9. Morita CT, Lee HK, Leslie DS, Tanaka Y, Bukowski JF, Marker-Hermann E: Recognition of nonpeptide prenyl pyrophosphate antigens by human γ/δ T cells. Microbes Infect 1999;1:175-186.
10. Chen ZW, Letvin NL: Adaptive immune response of Vγ2Vδ2 T cells: A new paradigm. Trends Immunol 2003;24:213-219.
11. Wang H, Lee HK, Bukowski JF, Li H, Mariuzza RA, Chen ZW, Nam KH, Morita CT: Conservation of nonpeptide antigen recognition by rhesus monkey Vγ2Vδ2 T cells. J Immunol 2003;170:3696-3706.
12. Shen Y, Zhou DJ, Qiu LY, Lai XM, Simon M, Shen L, Kou ZC, Wang QF, Jiang JM, Estep J, Hunt R, Clagett M, Sehgal PK, Li YY, Zeng XJ, Morita CT, Brenner MB, Lenin NL, Chen ZW: Adaptive immune response of Vγ2Vδ2(+) T cells during mycobacterial infections. Science 2002;295: 2255-2258.
13. Mestas J, Hughes CC: Of mice and not men: Differences between mouse and human immunology. J Immunol 2004;172:2731-2738.
14. Gober HJ, Kistowska M, Angman L, Jeno P, Mori L, De Libero G: Human T cell receptor γδ cells recognize endogenous mevalonate metabolites in tumor cells. J Exp Med 2003;197:163-168.
15. Altincicek B, Moll J, Campos N, Foerster G, Beck E, Hoeffler JF, Grosdemange-Billiard C, Rodriguez-Concepcion M, Rohmer M, Boronat A, Eberl M, Jomaa H: Cutting edge: Human γδ T cells are activated by intermediates of the 2-C-methyl-D-erythritol 4-phosphate pathway of isoprenoid biosynthesis. J Immunol 2001;166:3655-3658.
16. Eberl M, Hintz M, Reichenberg A, Kollas AK, Wiesner J, Jomaa H: Microbial isoprenoid biosynthesis and human γδ T cell activation. FEBS Lett 2003;544:4-10.
17. Eberl M, Jomaa H, Hayday AC: Integrated immune responses to infection - Cross-talk between human γδ T cells and dendritic cells. Immunology 2004;112:364-368.
18. Feurle J, Espinosa E, Eckstein S, Pont F, Kunzmann V, Fournie JJ, Herderich M, Wilhelm M: Escherichia coli produces phosphoantigens activating human γ/δ T cells. J Biol Chem 2002;277: 148-154.
19. Belmant C, Espinosa E, Poupot R, Peyrat MA, Guiraud M, Poquet Y, Bonneville M, Fournie JJ: 3-Formyl-1-butyl pyrophosphate A novel mycobacterial metabolite-activating human γδ T cells. J Biol Chem 1999;274:32079-32084.
20. Begley M, Gahan CG, Kollas AK, Hintz M, Hill C, Jomaa H, Eberl M: The interplay between classical and alternative isoprenoid biosynthesis controls γδ T cell bioactivity of Listeria monocytogenes. FEBS Lett 2004;561:99-104.
21. Altincicek B, Duin EC, Reichenberg A, Hedderich R, Kollas AK, Hintz M, Wagner S, Wiesner J, Beck E, Jomaa H: LytB protein catalyzes the terminal step of the 2-C-methyl-D-erythritol-4-phosphate pathway of isoprenoid biosynthesis. FEBS Lett 2002;532:437-440.
22. Kollas AK, Duin EC, Eberl M, Altincicek B, Hintz M, Reichenberg A, Henschker D, Henne A, Steinbrecher I, Ostrovsky DN, Hedderich R, Beck E, Jomaa H, Wiesner J: Functional characterization of GcpE, an essential enzyme of the non-mevalonate pathway of isoprenoid biosynthesis. FEBS Lett 2002;532:432-436.
23. Eberl M, Jomaa H: A genetic basis for human γδ T-cell reactivity towards microbial pathogens. Trends Immunol 2003;24:407-409.
24. Bukowski JF, Morita CT, Brenner MB: Human γδ T cells recognize alkylamines derived from microbes, edible plants, and tea: Implications for innate immunity. Immunity 1999;11:57-65.
25. Kamath AB, Wang L, Das H, Li L, Reinhold VN, Bukowski JF: Antigens in tea-beverage prime human Vγ2Vδ2 T cells in vitro and in vivo for memory and nonmemory antibacterial cytokine responses. Proc Natl Acad Sci USA 2003;100:6009-6014.
26. Kunzmann X Bauer E, Feurle J, Weissinger F, Tony HP, Wilhelm M: Stimulation of γδ T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma. Blood 2000;96:384-392.
27. Das H, Wang L, Kamath A, Bukowski JF: Vγ2Vδ2 T-cell receptor-mediated recognition of aminobisphosphonates. Blood 2001;98:1616-1618.
28. Miyagawa F, Tanaka Y, Yamashita S, Mikami B, Danno K, Uehara M, Minato N: Essential contribution of germline-encoded lysine residues in Jγ1.2 segment to the recognition of nonpeptide antigens by human γδ T cells. J Immunol 2001;167:6773-6779.
29. Thompson K, Rogers MJ: Statins prevent bisphosphonate-induced γδ-T-cell proliferation and activation in vitro. J Bone Miner Res 2004;19:278-288.
30. Sanders JM, Ghosh S, Chan JM, Meints G, Wang H, Raker AM, Song Y, Colantino A, Burzynska A, Kafarski P, Morita CT, Oldfield E: Quantitative structure-activity relationships for γδ T cell activation by bisphosphonates. J Med Chem 2004;47:375-384.
31. Green AE, Lissina A, Hutchinson SL, Hewitt RE, Temple B, James D, Boulter JM, Price DA, Sewell AK: Recognition of nonpeptide antigens by human Vγ9Vδ2 T cells requires contact with cells of human origin. Clin Exp Immunol 2004;136:472-482.
32. Lang F, Peyrat MA, Constant P, Davodeau F, David-Ameline J, Poquet Y, Vie H, Fournie JJ, Bonneville M: Early activation of human Vγ9Vδ2 T cell broad cytotoxicity and TNF production by nonpeptidic mycobacterial ligands. J Immunol 1995;154:5986-5994.
33. Wang L, Das H, Kamath A, Bukowski JF: Human Vγ2Vδ2 T cells produce IFN-γ and TNF-α with an on/off/on cycling pattern in response to live bacterial products. J Immunol 2001;167: 6195-6201.
34. Wang L, Kamath A, Das H, Li L, Bukowski JF: Antibacterial effect of human Vγ2Vδ2 T cells in vivo. J Clin Invest 2001;108:1349-1357.
35. Kato Y, Tanaka Y, Tanaka H, Yamashita S, Minato N: Requirement of species-specific interactions for the activation of human γδ T cells by pamidronate. J Immunol 2003;170:3608-3613.
36. Tanaka Y, Morita CT, Nieves E, Brenner MB, Bloom BR: Natural and synthetic nonpeptide antigens recognized by human γδ T cells. Nature 1995;375:155-158.
37. Tanaka Y, Sano S, Nieves E, De Libero G, Rosa D, Modlin RL, Brenner MB, Bloom BR, Morita CT: Nonpeptide ligands for human γδ T cells. Proc Natl Acad Sci USA 1994;91: 8175-8179.
38. Bukowski JF, Morita CT, Band H, Brenner MB: Crucial role of TCR γ chain junctional region in prenyl pyrophosphate antigen recognition by γδ T cells. J Immunol 1998;161:286-293.
39. Yamashita S, Tanaka Y, Harazaki M, Mikami B, Minato N: Recognition mechanism of nonpeptide antigens by human γδ T cells. Int Immunol 2003;15:1301-1307.
40. Nishimura H, Hirokawa M, Fujishima N, Fujishima M, Miura I, Sawada K: Contribution of complementarity-determining region 3 of the T-cell receptor Vδ2 chain to the recognition of aminobisphosphonates by human γδ T-cells. Int J Hematol 2004;79:369-376.
41. Parker CM, Groh V, Band H, Porcelli SA, Morita C, Fabbi M, Glass D, Strominger JL, Brenner MB: Evidence for extrathymic changes in the T cell receptor gamma/delta repertoire. J Exp Med 1990; 171:1597-1612.
42. De Rosa SC, Andrus JP, Perfetto SP, Mantovani JJ, Herzenberg LA, Herzenberg LA, Roederer M: Ontogeny of γδ T cells in humans. J Immunol 2004;172:1637-1645.
43. Holtmeier W, Chowers Y, Lumeng A, Morzycka-Wroblewska E, Kagnoff MF: The δ T cell receptor repertoire in human colon and peripheral blood is oligoclonal irrespective of V region usage. J Clin Invest 1995;96:1108-1117.
44. Allison TJ, Garboczi DN: Structure of γδ T cell receptors and their recognition of nonpeptide antigens. Mol Immunol 2002;38:1051-1061.
45. Fisch P, Malkovsky M, Kovats S, Sturm E, Braakman E, Klein BS, Voss SD, Morrissey LW, DeMars R, Welch WJ: Recognition by human Vγ9/Vδ2 T cells of a GroEL homolog on Daudi Burkitt's lymphoma cells. Science 1990;250:1269-1273.
46. Alexandroff AB, Jackson AM, O'Donnell MA, James K: BCG immunotherapy of bladder cancer: 20 years on. Lancet 1999;353:1689-1694.
47. Alexandroff AB, Black J, Bollina P, Esuvaranathan K, James K: Are γδ T lymphocytes involved in intravesical bacillus Calmette-Guerin immunotherapy of bladder cancer? Biochem Soc Trans 1997;25:363S.
48. Kato Y, Tanaka Y, Miyagawa F, Yamashita S, Minato N: Targeting of tumor cells for human γδ T cells by nonpeptide antigens. J Immunol 2001;167:5092-5098.
49. Kabelitz D, Bender A, Prospero T, Wesselborg S, Janssen O, Pechhold K: The primary response of human γ/δ+ T cells to Mycobacterium tuberculosis is restricted to Vγ9-bearing cells. J Exp Med 1991;173:1331-1338.
50. Lamb LS Jr, Henslee-Downey PJ, Parrish RS, Godder K, Thompson J, Lee C, Gee AP: Increased frequency of TCR γδ+ T cells in disease-free survivors following T cell-depleted, partially mismatched, related donor bone marrow transplantation for leukemia. J Hematother 1996;5: 503-509.
51. Kunzmann V, Bauer E, Wilhelm M: γ/δ T-cell stimulation by pamidronate. N Engl J Med 1999;340:737-738.
52. Wilhelm M, Kunzmann V, Eckstein S, Reimer P, Weissinger F, Ruediger T, Tony HP: γδ T cells for immune therapy of patients with lymphoid malignancies. Blood 2003;102:200-206.
53. Dieli F, Gebbia N, Poccia F, Caccamo N, Montesano C, Fulfaro F, Arcara C, Valerio MR, Meraviglia S, Di Sano C, Sireci G, Salerno A: Induction of γ/δ T-lymphocyte effector functions by bisphosphonate zoledronic acid in cancer patients in vivo. Blood 2003;102:2310-2311.
54. Schilbach K, Geiselhart A, Handgretinger R: Induction of proliferation and augmented cytotoxicity of γδ T lymphocytes by bisphosphonate clodronate. Blood 2001;97:2917-2918.
55. Kabelitz D: Characterization of tumor reactivity of human Vγ9Vδ2 γδ T-cells in vitro and in severe combined immunodeficiency mice in vivo. J Immunol 2004;173:6767-6776.
56. Fischer S, Scheffler A, Kabelitz D: Activation of human γ/δ T-cells by heat-treated mistletoe plant extracts. Immunol Lett 1996;52:69-72.
57. Fischer S, Scheffler A, Kabelitz D: Stimulation of the specific immune system by mistletoe extracts. Anticancer Drugs 1997;8(suppl I):S33-S37.
58. Espinosa E, Belmant C, Pont F, Luciani B, Poupot R, Romagne F, Brailly H, Bonneville M, Fournie JJ: Chemical synthesis and biological activity of bromohydrin pyrophosphate, a potent stimulator of human γδ T cells. J Biol Chem 2001;276:18337-18344.
59. Kabelitz D, Wesch D, Fitters EZM: Potential of human γδ T-lymphocytes for immmuntherapy of cancer. Int J Cancer 2004;112:727-732.
60. Holtmeier W: Compartmentalization of γ/δ T cells and their putative role in mucosal immunity. Crit Rev Immunol 2003;23:473-488.
61. Bukowski JF, Morita CT, Tanaka Y, Bloom BR, Brenner MB, Band H: Vγ2Vδ2 TCR-dependent recognition of non-peptide antigens and Daudi cells analyzed by TCR gene transfer. J Immunol 1995;154:998-1006.
62. Groh V, Steinle A, Bauer S, Spies T: Recognition of stress-induced MHC molecules by intestinal epithelial γ/δ T cells. Science 1998;279:1737-1740.
63. Spies T: Induction of T cell alertness by bacterial colonization of intestinal epithelium. Proc Natl Acad Sci USA 2002;99:2584-2586.
64. Pardoll DM: Immunology - Stress, NK receptors, and immune surveillance. Science 2001;294: 534-536.
65. Havran WL, Chien YH, Allison JP: Recognition of self antigens by skin-derived T cells with invariant γ/δ antigen receptors. Science 1991;252:1430-1432.
66. Chowers Y, Holtmeier W, Harwood J, Morzycka-Wroblewska E, Kagnoff MF: The Vδ1 T cell receptor repertoire in human small intestine and colon. J Exp Med 1994;180:183-190.
67. Holtmeier W, Witthöft T, Hennemann A, Winter HS, Kagnoff MF: The TCR-δ repertoire in human intestine undergoes characteristic changes during fetal to adult development. J Immunol 1997; 158:5632-5641.
68. Holtmeier W, Käller J, Geisel W, Pabst R, Caspary WF, Rothkötter HJ: Development and compartmentalization of the porcine TCR δ repertoire at mucosal and extraintestinal sites: The pig as a model for analyzing the effects of age and microbial factors. J Immunol 2002;169: 1993-2002.
69. Holtmeier W, Pfänder M, Hennemann A, Zollner TM, Kaufmann R, Caspary WF: The TCR δ repertoire in normal human skin is restricted and distinct from the TCR δ repertoire in the peripheral blood. J Invest Dermatol 2001;116:275-280.
70. Groh V, Bahram S, Bauer S, Herman A, Beauchamp M, Spies T: Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc Natl Acad Sci USA 1996;93:12445-12450.
71. Das H, Groh V, Kuijl C, Sugita M, Morita CT, Spies T, Bukowski JF: MICA engagement by human Vγ2Vδ2 T cells enhances their antigen-dependent effector function. Immunity 2001;15:83-93.
72. Steinle A, Groh V, Spies T: Diversification, expression, and γδ T cell recognition of evolutionarily distant members of the MIC family of major histocompatibility complex class I-related molecules. Proc Natl Acad Sci USA 1998;95:12510-12515.
73. Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lamer LL, Spies T: Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999;285:727-729.
74. Roberts AI, Lee L, Schwarz E, Groh V, Spies T, Ebert EC, Jabri B: NKG2D receptors induced by IL-15 costimulate CD28-negative effector CTL in the tissue microenvironment. J Immunol 2001;167:5527-5530.
75. Ohteki T: Critical role for IL-15 in innate immunity. Curr Mol Med 2002;2:371-380.
76. Garcia VE, Jullien D, Song M, Uyemura K, Shuai K, Morita CT, Modlin RL: IL-15 enhances the response of human γ/δ T cells to nonpeptide microbial antigens. J Immunol 1998;160:4322-4329.
77. Groh V, Rhinehart R, Secrist H, Bauer S, Grabstein KH, Spies T: Broad tumor-associated expression and recognition by tumor-derived γ/δ T cells of MICA and MICB. Proc Natl Acad Sci USA 1999;96:6879-6884.
78. Wu J, Groh V, Spies T: T cell antigen receptor engagement and specificity in the recognition of stress-inducible MHC class I-related chains by human epithelial γ/δ T cells. J Immunol 2002;169: 1236-1240.
79. Takeda K, Kaisho T, Akira S: Toll-like receptors. Annu Rev Immunol 2003;21:335-376.
80. Leslie DS, Vincent MS, Spada FM, Das H, Sugita M, Morita CT, Brenner MB: CD1-mediated γ/δ T cell maturation of dendritic cells. J Exp Med 2002;196:1575-1584.
81. Vincent MS, Leslie DS, Gumperz JE, Xiong X, Grant EP, Brenner MB: CD1-dependent dendritic cell instruction. Nat Immunol 2002;3:1163-1168.
82. Ismaili J, Olislagers V, Poupot R, Fournie JJ, Goldman M: Human γ/δ T cells induce dendritic cell maturation. Clin Immunol 2002;103:296-302.
83. Jameson J, Witherden D, Havran WL: T-cell effector mechanisms: γ/δ and CD1d-restricted subsets. Curr Opin Immunol 2003;15:349-353.
84. Spada FM, Grant EP, Peters PJ, Sugita M, Melian A, Leslie DS, Lee HK, van Donselaar E, Hanson DA, Krensky AM, Majdic O, Porcelli SA, Morita CT, Brenner MB: Self-recognition of CD1 by γ/δ T cells: Implications for innate immunity. J Exp Med 2000;191:937-948.
85. Beckman EM, Porcelli SA, Morita CT, Behar SM, Furlong ST, Brenner MB: Recognition of a lipid antigen by CD1-restricted ααβ+ T cells. Nature 1994;372:691-694.
86. Matsuda JL, Kronenberg M: Presentation of self and microbial lipids by CD1 molecules. Curr Opin Immunol 2001;13:19-25.
87. De Libero G, Mori L: Self glycosphingolipids: New antigens recognized by autoreactive T lymphocytes. News Physiol Sci 2003;18:71-76.
88. Das H, Sugita M, Brenner MB: Mechanisms of Vδ1 γδ T cell activation by microbial components. J Immunol 2004;172:6578-6586.
89. Deusch K, Luling F, Reich K, Classen M, Wagner H, Pfeffer K: A major fraction of human intraepithelial lymphocytes simultaneously expresses the γ/δ T cell receptor, the CD8 accessory molecule and preferentially uses the Vδ1 gene segment. Eur J Immunol 1991;21:1053-1059.
90. Holtmeier W, Hennemann A, May E, Duchmann R, Caspary WF: T cell receptor δ repertoire in inflamed and noninflamed colon of patients with IBD analyzed by CDR3 spectratyping. Am J Physiol 2002;282:G1024-G1034.
91. Thielke KH, Hoffmann-Moujahid A, Weisser C, Waldkirch E, Pabst R, Holtmeier W, Rothkötter HJ: Proliferating intestinal γ/δ T cells recirculate rapidly and are a major source of the γ/δ T cell pool in the peripheral blood. Eur J Immunol 2003;33:1649-1656.
92. Holtmeier W, Geisel W, Bernert K, Butler JE, Sinkora M, Rehakova Z, Sinkora J, Caspary WF: Prenatal development of the porcine TCR δ repertoire: Dominant expression of an invariant T cell receptor Vδ3-Jδ3 chain. Eur J Immunol 2004;34:1941-1949.
93. Dunkley M, Pabst R, Cripps A: An important role for intestinally derived T cells in respiratory defence. Immunol Today 1995;16:231-236.
94. Dechanet J, Merville P, Lim A, Retiere C, Pitard V, Lafarge X, Michelson S, Meric C, Hallet MM, Kourilsky P, Potaux L, Bonneville M, Moreau JF: Implication of γδ T cells in the human immune response to cytomegalovirus. J Clin Invest 1999;103:1437-1449.
95. Boullier S, Cochet M, Poccia F, Gougeon ML: CDR3-independent γδ Vδ1 + T cell expansion in the peripheral blood of HIV-infected persons. J Immunol 1995;154:1418-1431.
96. Hinz T, Wesch D, Friese K, Reckziegel A, Arden B, Kabelitz D: T cell receptor γδ repertoire in HIV-1-infected individuals. Eur J Immunol 1994;24:3044-3049.
97. Poccia F, Boullier S, Lecoeur H, Cochet M, Poquet Y, Colizzi V, Fournie JJ, Gougeon ML: Peripheral Vγ9/Vδ2 T cell deletion and anergy to nonpeptidic mycobacterial antigens in asymptomatic HIV-1-infected persons. J Immunol 1996;157:449-461.
98. Dechanet J, Merville P, Pitard V, Lafarge X, Moreau JF: Human γδ T cells and viruses. Microbes Infect 1999;1:213-217.
99. Lehner T, Mitchell E, Bergmeier L, Singh M, Spallek R, Cranage M, Hall G, Dennis M, Villinger F, Wang Y: The role of γ/δ T cells in generating antiviral factors and β-chemokines in protection against mucosal simian immunodeficiency virus infection. Eur J Immunol 2000;30:2245-2256.
100. Hyjek EM, Bartkowiak J, Drozdz R, Wasik TJ, Jasinski M, Kaneko Y, Lischner HW, Kozbor D: Evidence for B cell-mediated activation of Vδ1 + T lymphocytes during progression of HIV infection. J Immunol 1997;158:464-474.
101. Glatzel A, Entschladen F, Zollner TM, Kraiczy P, Brade V, Kaufmann R, Janssen O, Lengl-Janssen B, Wesch D, Kabelitz D: The responsiveness of human Vδ1 γδ T cells to Borrelia burgdorferi is largely restricted to synovial-fluid cells from patients with Lyme arthritis. J Infect Dis 2002;186: 1043-1046.
102. Vincent MS, Roessner K, Lynch D, Wilson D, Cooper SM, Tschopp J, Sigal LH, Budd RC: Apoptosis of Fashigh CD4+ synovial T cells by borrelia-reactive Fas-ligand(high) γδ T cells in Lyme arthritis. J Exp Med 1996;184:2109-2117.
103. Vincent MS, Roessner K, Sellati T, Huston CD, Sigal LH, Behar SM, Radolf JD, Budd RC: Lyme arthritis synovial γδ T cells respond to Borrelia burgdorferi lipoproteins and lipidated hexapeptides. J Immunol 1998;161:5762-5771.
104. Uyemura K, Deans RJ, Band H, Ohmen J, Panchamoorthy G, Morita CT, Rea TH, Modlin RL: Evidence for clonal selection of γ/δ T cells in response to a human pathogen. J Exp Med 1991; 174:683-692.
105. Ferrarini M, Heltai S, Chiesa G, Sabbadini MG: Vδ1 + γ/δ T lymphocytes infiltrating human lung cancer express the CD8 α/α homodimer. Scand J Immunol 1994;40:363-367.
106. Zocchi MR, Ferrarini M, Migone N, Casorati G: T-cell receptor Vδ gene usage by tumour reactive γδ T lymphocytes infiltrating human lung cancer. Immunology 1994;81:234-239.
107. Maeurer MJ, Martin D, Walter W, Liu K, Zitvogel L, Halusczcak KX, Rabinowich H, Storkus W, Lotze MT: Human intestinal Vδ1 + lymphocytes recognize tumor cells of epithelial origin. J Exp Med 1996;183:1681-1696.
108. Choudhary A, Davodeau F, Moreau A, Peyrat MA, Bonneville M, Jotereau F: Selective lysis of autologous tumor cells by recurrent γδ tumor-infiltrating lymphocytes from renal carcinoma. J Immunol 1995;154:3932-3940.
109. Thomas ML, Badwe RA, Deshpande RK, Samant UC, Chiplunkar SV: Role of adhesion molecules in recruitment of Vδ1 T cells from the peripheral blood to the tumor tissue of esophageal cancer patients. Cancer Immunol Immunother 2001;50:218-225.
110. Lozupone F, Pende D, Burgio VL, Castelli C, Spada M, Venditti M, Luciani F, Lugini L, Federici C, Ramoni C, Rivoltini L, Parmiani G, Belardelli F, Rivera P, Marcenaro S, Moretta L, Fais S: Effect of human natural killer and γδ T cells on the growth of human autologous melanoma xenografts in SCID mice. Cancer Res 2004;64:378-385.
111. Vetter CS, Groh V, Straten PT, Spies T, Brocker EB, Becker JC: Expression of stress-induced MHC class I related chain molecules on human melanoma. J Invest Dermatol 2002;118:600-605.
112. Ferrarini M, Ferrero E, Dagna L, Poggi A, Zocchi MR: Human γδ T cells: A nonredundant system in the immune-surveillance against cancer. Trends Immunol 2002;23:14-18.
113. Qi J, Zhang J, Zhang S, Cui L, He W: Immobilized MICA could expand human Vδ1 γδ T cells in vitro that displayed major histocompatibility complex class I chain-related A-dependent cytotoxicity to human epithelial carcinomas. Scand J Immunol 2003;58:211-220.
114. Gao Y, Yang W, Pan M, Scully E, Girardi M, Augenlicht LH, Craft J, Yin Z: γδ T cells provide an early source of interferon γ in tumor immunity. J Exp Med 2003;198:433-442.
115. Girardi M, Oppenheim DE, Steele CR, Lewis JM, Glusac E, Filler R, Hobby P, Sutton B, Tigelaar RE, Hayday AC: Regulation of cutaneous malignancy by γ/δ T cells. Science 2001;294: 605-609.
116. Girardi M, Glusac E, Filler RB, Roberts SJ, Propperova I, Lewis J, Tigelaar RE, Hayday AC: The distinct contributions of murine T cell receptor (TCR)γ/δ+ and TCRααβ+ T cells to different stages of chemically induced skin cancer. J Exp Med 2003;198:747-755.
117. Groh V, Wu J, Yee C, Spies T: Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature 2002;419:734-738.
118. Lamb LS Jr, Musk P, Ye Z, van Rhee F, Geier SS, Tong JJ, King KM, Henslee-Downey PJ: Human γδ(+) T lymphocytes have in vitro graft vs leukemia activity in the absence of an allogeneic response. Bone Marrow Transplant 2001;27:601-606.
119. Duval M, Yotnda P, Bensussan A, Oudhiri N, Guidal C, Rohrlich P, Boumsell L, Grandchamp B, Vilmer E: Potential antileukemic effect of γδ T cells in acute lymphoblastic leukemia. Leukemia 1995;9:863-868.
120. Hacker G, Kromer S, Falk M, Heeg K, Wagner H, Pfeffer K: Vδ1 + subset of human γδ T cells responds to ligands expressed by EBV-infected Burkitt lymphoma cells and transformed B lymphocytes. J Immunol 1992;149:3984-3989.
121. Fisch P, Oettel K, Fudim N, Surfus JE, Malkovsky M, Sondel PM: MHC-unrestricted cytotoxic and proliferative responses of two distinct human γδ T cell subsets to Daudi cells. J Immunol 1992;148:2315-2323.
122. Abitorabi MA, Mackay CR, Jerome EH, Osorio O, Butcher EC, Erle DJ: Differential expression of homing molecules on recirculating lymphocytes from sheep gut, peripheral, and lung lymph. J Immunol 1996;156:3111-3117.
123. von Andrian UH, Mackay CR: Advances in immunology: T-cell function and migration - Two sides of the same coin. N Engl J Med 2000;343:1020-1033.
124. Wilson E, Hedges JF, Butcher EC, Briskin M, Jutila MA: Bovine γ/δ T cell subsets express distinct patterns of chemokine responsiveness and adhesion molecules: A mechanism for tissue-specific γ/δ T cell subset accumulation. J Immunol 2002;169:4970-4975.
125. Chao CC, Sandor M, Dailey MO: Expression and regulation of adhesion molecules by γ/δ T cells from lymphoid tissues and intestinal epithelium. Eur J Immunol 1994;24:3180-3187.
126. Roth SJ, Diacovo TG, Brenner MB, Rosat JP, Buccola J, Morita CT, Springer TA: Transendothelial chemotaxis of human ααβ and γ/δ T lymphocytes to chemokines. Eur J Immunol 1998;28: 104-113.
127. Glatzel A, Wesch D, Schiemann F, Brandt E, Janssen O, Kabelitz D: Patterns of chemokine receptor expression on peripheral blood γ/δ T lymphocytes: Strong expression of CCR5 is a selective feature of Vδ2/Vγ9 γ/δ T cells. J Immunol 2002;168:4920-4929.
128. Romagnani P, Annunziato F, Lazzeri E, Cosmi L, Beltrame C, Lasagni L, Galli G, Francalanci M, Manetti R, Marra F, Vanini V, Maggi E, Romagnani S: Interferon-inducible protein 10, monokine induced by interferon γ, and interferon-inducible T-cell α-chemoattractant are produced by thymic epithelial cells and attract T-cell receptor (TCR) ααβ (+)CD8(+) single-positive T cells, TCR γ/δ (+) T cells, and natural killer-type cells in human thymus. Blood 2001;97:601-607.
129. Ferrero E, Biswas P, Vettoretto K, Ferrarini M, Uguccioni M, Piali L, Leone BE, Moser B, Rugarli C, Pardi R: Macrophages exposed to Mycobacterium tuberculosis release chemokines able to recruit selected leukocyte subpopulations: Focus on γ/δ cells. Immunology 2003;108:365-374.
130. Ladel CH, Hess J, Daugelat S, Mombaerts P, Tonegawa S, Kaufmann SH: Contribution of ααβ β and γ/δ T lymphocytes to immunity against Mycobacterium bovis bacillus Calmette Guerin: Studies with T cell receptor-deficient mutant mice. Eur J Immunol 1995;25:838-846.
131. Boom WH: γ/δ T cells and Mycobacterium tuberculosis. Microbes Infect 1999;1:187-195.
132. Cipriani B, Borsellino G, Poccia F, Placido R, Tramonti D, Bach S, Battistini L, Brosnan CF: Activation of C-C β-chemokines in human peripheral blood γ/δ T cells by isopentenyl pyrophosphate and regulation by cytokines. Blood 2000;95:39-47.
133. Murzenok PP, Matusevicius D, Freedman MS: γ/δ T cells in multiple sclerosis: Chemokine and chemokine receptor expression. Clin Immunol 2002;103:309-316.
134. Sallusto F, Kremmer E, Palermo B, Hoy A, Ponath P, Qin S, Forster R, Lipp M, Lanzavecchia A: Switch in chemokine receptor expression upon TCR stimulation reveals novel homing potential for recently activated T cells. Eur J Immunol 1999;29:2037-2045.
135. Brandes M, Willimann K, Lang AB, Nam KH, Jin C, Brenner MB, Morita CT, Moser B: Flexible migration program regulates γ/δ T-cell involvement in humoral immunity. Blood 2003;102: 3693-3701.
136. Dieli F, Poccia F, Lipp M, Sireci G, Caccamo N, Di Sano C, Salerno A: Differentiation of effector/memory Vδ2 T cells and migratory routes in lymph nodes or inflammatory sites. J Exp Med 2003;198:391-397.
137. Mackay CR: Dual personality of memory T cells. Nature 1999;401:659-660.
138. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A: Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999;401:708-712.
139. Eberl M, Engel R, Beck E, Jomaa H: Differentiation of human γ/δ T cells towards distinct memory phenotypes. Cell Immunol 2002;218:1-6.
140. Luster AD: Chemokines: Chemotactic cytokines that mediate inflammation. N Engl J Med 1998;338:436-445.
141. Colantonio L, Recalde H, Sinigaglia F, D'Ambrosio D: Modulation of chemokine receptor expression and chemotactic responsiveness during differentiation of human naive T cells into Th1 or Th2 cells. Eur J Immunol 2002;32:1264-1273.
142. Sallusto F, Lenig D, Mackay CR, Lanzavecchia A: Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 1998;187:875-883.
143. Wen L, Barber DF, Pao W, Wong FS, Owen MJ, Hayday A: Primary γ/δ cell clones can be defined phenotypically and functionally as Th1/Th2 cells and illustrate the association of CD4 with Th2 differentiation. J Immunol 1998;160:1965-1974.
144. Wesch D, Glatzel A, Kabelitz D: Differentiation of resting human peripheral blood γ/δ T cells toward Th1- or Th2-phenotype. Cell Immunol 2001;212:110-117.
145. Dagna L, Iellem A, Biswas P, Resta D, Tantardini F, Fortis C, Sabbadini MG, D'Ambrosio D, Manfredi AA, Ferrarini M: Skewing of cytotoxic activity and chemokine production, but not of chemokine receptor expression, in human type-1/-2 γ/δ T lymphocytes. Eur J Immunol 2002;32:2934-2943.
146. Wagner N, Lohler J, Kunkel EJ, Ley K, Leung E, Krissansen G, Rajewsky K, Muller W: Critical role for 1β7 integrins in formation of the gut-associated lymphoid tissue. Nature 1996;382: 366-370.
147. Uehara S, Grinberg A, Farber JM, Love PE: A role for CCR9 in T lymphocyte development and migration. J Immunol 2002;168:2811-2819.
148. Wurbel MA, Philippe JM, Nguyen C, Victorero G, Freeman T, Wooding P, Miazek A, Mattei MG, Malissen M, Jordan BR, Malissen B, Carrier A, Naquet P: The chemokine TECK is expressed by thymic and intestinal epithelial cells and attracts double- and single-positive thymocytes expressing the TECK receptor CCR9. Eur J Immunol 2000;30:262-271.
149. Zabel BA, Agace WW, Campbell JJ, Heath HM, Parent D, Roberts AI, Ebert EC, Kassam N, Qin SX, Zovko M, Larosa GJ, Yang LL, Soler D, Butcher EC, Ponath PD, Parker CM, Andrew DP: Human G protein-coupled receptor GPR-9-G/CC chemokine receptor 9 is selectively expressed on intestinal homing T lymphocytes, mucosal lymphocytes, and thymocytes and is required for thymus-expressed chemokine-mediated chemotaxis. J Exp Med 1999;190:1241-1255.
150. Kunkel EJ, Campbell JJ, Haraldsen G, Pan JL, Boisvert J, Roberts AI, Ebert EC, Vierra MA, Goodman SB, Genovese MC, Wardlaw AJ, Greenberg HB, Parker CM, Butcher EC, Andrew DP, Agace WW: Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: Epithelial expression of tissue- specific chemokines as an organizing principle in regional immunity. J Exp Med 2000;192:761-767.
151. Papadakis KA, Prehn J, Nelson V, Cheng L, Binder SW, Ponath PD, Andrew DP, Targan SR: The role of thymus-expressed chemokine and its receptor CCR9 on lymphocytes in the regional specialization of the mucosal immune system. J Immunol 2000;165:5069-5076.
152. Wurbel MA, Malissen M, Guy-Grand D, Meffre E, Nussenzweig MC, Richelme M, Carrier A, Malissen B: Mice lacking the CCR9 CC-chemokine receptor show a mild impairment of early T- and B-cell development and a reduction in T-cell receptor γ/δ (+) gut intraepithelial lymphocytes. Blood 2001;98:2626-2632.
153. Uehara S, Song KM, Farber JM, Love PE: Characterization of CCR9 expression and CCL25/thymus-expressed chemokine responsiveness during T cell development: CD3(high) CD69(+) thymocytes and γ/δ TCR + thymocytes preferentially respond to CCL25. J Immunol 2002; 168: 134-142.
154. Marsal J, Svensson M, Ericsson A, Iranpour AH, Carramolino L, Marquez G, Agace WW: Involvement of CCL25 (TECK) in the generation of the murine small-intestinal CD8α α+CD3+ intraepithelial lymphocyte compartment. Eur J Immunol 2002;32:3488-3497.
155. Onai N, Kitabatake M, Zhang YY, Ishikawa H, Ishikawa S, Matsushima K: Pivotal role of CCL25 (TECK)-CCR9 in the formation of gut cryptopatches and consequent appearance of intestinal intraepithelial T lymphocytes. Int Immunol 2002;14:687-694.
156. Mora JR, Bono MR, Manjunath N, Weninger W, Cavanagh LL, Rosenblatt M, von Andrian UH: Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells. Nature 2003;424: 88-93.
157. Kunkel EJ, Campbell DJ, Butcher EC: Chemokines in lymphocyte trafficking and intestinal immunity. Microcirculation 2003;10:313-323.
158. Cyster JG: Homing of antibody secreting cells. Immunol Rev 2003;194:48-60.
159. Nakayama T, Hieshima K, Izawa D, Tatsumi Y, Kanamaru A, Yoshie O: Cutting edge: Profile of chemokine receptor expression on human plasma cells accounts for their efficient recruitment to target tissues. J Immunol 2003;170:1136-1140.
160. Kunkel EJ, Kim CH, Lazarus NH, Vierra MA, Soler D, Bowman EP, Butcher EC: CCR10 expression is a common feature of circulating and mucosal epithelial tissue IgA Ab-secreting cells. J Clin Invest 2003;111:1001-1010.
161. Soler D, Humphreys TL, Spinola SM, Campbell JJ: CCR4 versus CCR10 in human cutaneous TH lymphocyte trafficking. Blood 2003;101:1677-1682.
162. Campbell JJ, Haraldsen G, Pan J, Rottman J, Qin S, Ponath P, Andrew DP, Warnke R, Ruffing N, Kassam N, Wu L, Butcher EC: The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature 1999;400:776-780.
163. Hudak S, Hagen M, Liu Y, Catron D, Oldham E, Mcevoy LM, Bowman EP: Immune surveillance and effector functions of CCR10(+) skin homing T cells. J Immunol 2002;169:1189-1196.
164. Kapp JA, Kapp LM, McKenna KC: γ/δ T cells play an essential role in several forms of tolerance. Immunol Res 2004;29:93-102.
165. Kapp JA, Kapp LM, McKenna KC, Lake JP: γδ T-cell clones from intestinal intraepithelial lymphocytes inhibit development of CTL responses ex vivo. Immunology 2004;111:155-164.
166. McMenamin C, Pimm C, McKersey M, Holt PG: Regulation of IgE responses to inhaled antigen in mice by antigen-specific γδ T cells. Science 1994;265:1869-1871.
167. Mincheva-Nilsson L, Kling M, Hammarstrom S, Nagaeva O, Sundqvist KG, Hammarstrom ML, Baranov V: γδ T cells of human early pregnancy decidua: Evidence for local proliferation, phenotypic heterogeneity, and extrathymic differentiation. J Immunol 1997;159:3266-3277.
168. Barakonyi A, Kovacs KT, Miko E, Szereday L, Varga P, Szekeres-Bartho J: Recognition of nonclassical HLA class I antigens by γ/δ T cells during pregnancy. J Immunol 2002;168: 2683-2688.
169. Nagaeva O, Jonsson L, Mincheva-Nilsson L: Dominant IL-10 and TGF-β mRNA expression in γ/δ T cells of human early pregnancy decidua suggests immunoregulatory potential. Am J Reprod Immunol 2002;48:9-17.
170. Holt PG, Sly PD: γ/δ T cells provide a breath of fresh air for asthma research. Nat Med 1999;5:1127-1128.
171. McMenamin C, McKersey M, Kuhnlein P, Hunig T, Holt PG: γδ T cells down-regulate primary IgE responses in rats to inhaled soluble protein antigens. J Immunol 1995;154:4390-4394.
172. Lahn M, Kanehio A, Takeda K, Joetham A, Schwarze J, Kohler G, O'Brien R, Gelfand EW, Born W: Negative regulation of airway responsiveness that is dependent on γ/δ T cells and independent of ααβ T cells. Nat Med 1999;5:1150-1156.
173. Lahn M: The role of γ/δ T cells in the airways. J Mol Med 2000;78:409-425.
174. Workalemahu G, Foerster M, Kroegel C: Expression and synthesis of fibroblast growth factor-9 in human γδ T-lymphocytes. Response to isopenteny 1 pyrophosphate and TGF-β1/IL-15. J Leukoc Biol 2004;75:657-663.
175. Boismenu R, Havran WL: Modulation of epithelial cell growth by intraepithelial γ/δ T cells. Science 1994;266:1253-1255.
176. Havran WL: A role for epithelial γ/δ T cells in tissue repair. Immunol Res 2000;21:63-69.
177. Chen YP, Chou K, Fuchs E, Havran WL, Boismenu R: Protection of the intestinal mucosa by intraepithelial γ/δ T cells. Proc Natl Acad Sci USA 2002;99:14338-14343.
178. Workalemahu G, Foerster M, Kroegel C, Braun RK: Human γ/δ-T lymphocytes express and synthesize connective tissue growth factor: Effect of IL-15 and TGF-β1 and comparison with ααβ-T lymphocytes. J Immunol 2003;170:153-157.
179. Yang H, Antony PA, Wildhaber BE, Teitelbaum DH: Intestinal intraepithelial lymphocyte gammadelta-T cell-derived keratinocyte growth factor modulates epithelial growth in the mouse. J Immunol 2004;172:4151-4158.
180. Hoffmann JC, Peters K, Henschke S, Herrmann B, Pfister K, Westermann J, Zeitz M: Role of T lymphocytes in rat 2,4,6-trinitrobenzene sulphonic acid (TNBS) induced colitis: Increased mortality after γ/δ T cell depletion and no effect of ααββT cell depletion. Gut 2001;48: 489-495.
181. Guan H, Zu G, Slater M, Elmets C, Xu H: γ/δ T cells regulate the development of hapten-specific CD8+ effector T cells in contact hypersensitivity responses. J Invest Dermatol 2002;119: 137-142.
182. Girardi M, Lewis J, Glusac E, Filler RB, Geng L, Hayday AC, Tigelaar RE: Resident skin-specific γ/δ T cells provide local, nonredunda nt regulation of cutaneous inflammation. J Exp Med 2002;195:855-867.
183. Skeen MJ, Rix EP, Freeman MM, Ziegler HK: Exaggerated proinflammatory and Th1 responses in the absence of γ/δ T cells after infection with Listeria monocytogenes. Infect Immun 2001;69:7213-7223.
184. Egan PJ, Carding SR: Downmodulation of the inflammatory response to bacterial infection by γ/δ T cells cytotoxic for activated macrophages. J Exp Med 2000;191:2145-2158.
185. Seo N, Egawa K: Suppression of cytotoxic T lymphocyte activity by γ/δ T cells in tumor-bearing mice. Cancer Immunol Immunother 1995;40:358-366.
186. Seo N, Tokura Y, Takigawa M, Egawa K: Depletion of IL-10- and TGF-β-producing regulatory γ/δ T cells by administering a daunomycin-conjugated specific monoclonal antibody in early tumor lesions augments the activity of CTLs and NK cells. J Immunol 1999;163:242-249.
187. Ke Y, Kapp LM, Kapp JA: Inhibition of tumor rejection by γδ T cells and IL-10. Cell Immunol 2003;221:107-114.
188. Uezu K, Kawakami K, Miyagi K, Kinjo Y, Kinjo T, Ishikawa H, Saito A: Accumulation of γ/δ T cells in the lungs and their regulatory roles in Th1 response and host defense against pulmonary infection with Cryptococcus neoformans. J Immunol 2004;172:7629-7634.
189. Kopp E, Medzhitov R: Recognition of microbial infection by Toll-like receptors. Curr Opin Immunol 2003;15:396-401.
190. Caramalho I, Lopes-Carvalho T, Ostler D, Zelenay S, Haury M, Demengeot J: Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J Exp Med 2003;197:403-411.
191. Mokuno Y, Matsuguchi T, Takano M, Nishimura H, Washizu J, Ogawa T, Takeuchi O, Akira S, Nimura Y, Yoshikai Y: Expression of toll-like receptor 2 on γ/δ T cells bearing invariant Vγ6/Vδ1 induced by Escherichia coli infection in mice. J Immunol 2000;165:931-940.
192. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA: Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001;413:732-738.
193. Kunzmann V, Kretzschmar E, Hermann T, Wilhelm M: Polyinosinic- polycytidylic acid-mediated stimulation of human γδ T cells via CD11c dendritic cell-derived type I interferons. Immunology 2004;112:369-377.